FIM-X13

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameFIM-X13
Drug Alias NameFIM-X13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesFujian Institute Of Microbiology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFujian Institute Of Microbiology
Active IndicationsN/A
Inactive IndicationsStomach Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A